Market Overview

US Stock Futures Tumble Ahead Of Morgan Stanley Earnings

US Stock Futures Tumble Ahead Of Morgan Stanley Earnings
Related MS
How The SEC's Enforcement Division Is Responding To Cybersecurity Challenges
The Market In 5 Minutes: Tesla's Announcement, Major Earnings And Jobless Claims
Morgan Stanley Crushes It Again (Seeking Alpha)
Related TWX
Disney Needs To Focus Organically To Improve Consumer Distribution
Why T-Mobile Is The Likeliest Target For A Takeout Following Time Warner-AT&T Deal
Time Warner: No Deal = Not A Good Bet (Seeking Alpha)

Pre-open movers

US stock futures traded lower in early pre-market trade, ahead of earnings from Morgan Stanley (NYSE: MS). Data on weekly jobless claims and housing starts for June will be released at 8:30 a.m. ET. The general conditions index of the Philadelphia Fed's Survey will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average tumbled 71 points to 16,986.00, while the Standard & Poor's 500 index futures fell 12.60 points to 1,962.20. Futures for the Nasdaq 100 index dropped 26 points to 3,896.50.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index falling 1.21%, STOXX Europe 600 Index dropping 0.90%. German DAX 30 index declined 0.98%, French CAC 40 Index tumbled 1.06% and London's FTSE 100 Index dropped 0.73%.

In Asian markets, Japan's Nikkei Stock Average fell 0.06%, Hong Kong's Hang Seng Index declined 0.01%, China's Shanghai Composite Index dropped 0.57% and India's BSE Sensex gained 0.04%.

Broker Recommendation

Analysts at Janney Capital upgraded Time Warner (NYSE: TWX) from Neutral to Buy. The target price for Time Warner has been raised from $71.90 to $100.

Time Warner's shares closed at $83.13 yesterday.

Breaking news

  • Philip Morris International (NYSE: PM) reported better-than-expected second-quarter results. To read the full news, click here.
  • SAP SE (NYSE: SAP) reported a 23% drop in its second-quarter profit and lifted its full-year revenue forecast for cloud applications. To read the full news, click here.
  • Salix Pharmaceuticals (NASDAQ: SLXP) and Pharming Group NV (OTC: PHGUF) today announced that the Food and Drug Administration has approved RUCONEST (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg for the treatment of acute angioedema attacks in adult and adolescent patients with hereditary angioedema (HAE). To read the full news, click here.
  • Shares of UnitedHealth Group (NYSE: UNH) surged around 3.7% in pre-market trading after the company reported upbeat second-quarter earnings and raised its revenue forecast. To read the full news, click here.

Posted-In: Janney Capital US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (MS + PHGUF)

View Comments and Join the Discussion!